Eur Rev Med Pharmacol Sci 2020; 24 (23): 12016-12024
DOI: 10.26355/eurrev_202012_23990

Pro-inflammatory mediators and signaling proteins in the decidua of pre-eclampsia

K.-Y. Jung, L.P. Uprety, Y.-J. Jang, J.I. Yang

Department of Microbiology, Ajou University School of Medicine, Suwon, Korea. jangyj@ajou.ac.kr


OBJECTIVE: To evaluate the role of CD68+ macrophages and inflammatory/signaling proteins in the decidua of singleton pregnancies with late-onset pre-eclampsia.

PATIENTS AND METHODS: This study was designed as a prospective case-control study. Decidual tissue samples were obtained from twenty healthy pregnant women as a control group and twenty pregnant women with late-onset pre-eclampsia showing severe symptoms as the study group. We examined the abundance of CD68+ macrophages in both groups using flow cytometry. Protein and mRNA expression levels of inflammatory/signaling proteins, including inducible nitric oxide synthase, nuclear factor-κB inhibitor α, cyclooxygenase-2, and phosphorylated c-Jun N-terminal kinase, in the decidua of both groups were measured using Western blotting and Reverse Transcription-Polymerase Chain Reaction, respectively. Student’s t-tests were performed for statistical analysis.

RESULTS: The numbers of CD68+ macrophages were similar in the study and control groups (p=0.47). However, the levels of inducible nitric oxide synthase, nuclear factor-κB, cyclooxygenase-2, and phosphorylated c-Jun N-terminal kinase were significantly increased in the study group. Therefore, pro-inflammatory mediators and signaling proteins in the decidua during pre-eclampsia may be related to the pathogenesis of pre-eclampsia.

CONCLUSIONS: Pre-eclampsia-induced alterations in the expression of inflammatory/signaling proteins in the decidua during singleton pregnancies may play a critical role in the pathogenesis of pre-eclampsia.

Free PDF Download

To cite this article

K.-Y. Jung, L.P. Uprety, Y.-J. Jang, J.I. Yang
Pro-inflammatory mediators and signaling proteins in the decidua of pre-eclampsia

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 23
Pages: 12016-12024
DOI: 10.26355/eurrev_202012_23990